Combination broadens iRhythm’s cardiac monitoring portfolio, advances its multi-vitals strategy and expands iRhythm’s addressable market across the continuum of care.iRhythm’s commercial scale, health ...
Rhythm announced this week that it has completed its $287.5 million acquisition of cardiac monitoring tech company ...
Detailed price information for Irhythm Holdings Inc (IRTC-Q) from The Globe and Mail including charting and trades.
Growth is driven by rising cardiovascular disease, telehealth adoption, and advances in wearable ECG devices, implantable monitors, AI analytics, and cloud platforms. North America leads, while ...
iRhythm acquires VitalConnect to enhance its cardiac monitoring portfolio and expand market access, aiming for significant revenue growth by 2027.
Demand is rising for wearable, AI-enabled ECG and remote monitoring, driven by aging, cardiovascular disease, early diagnosis, telehealth and underserved regional communities.Dublin, Sept. 22, 2026 ...
Rising heart disease and home-based care are driving demand for wearable, AI-enabled cardiac devices, creating opportunities in remote monitoring and Asia-Pacific.Dublin, Sept. 16, 2026 (GLOBE ...
Rhythm completes its VitalConnect acquisition, expanding cardiac monitoring across ambulatory, inpatient and hospital-to-home ...
Rhythm just closed a $287.5M deal for San Jose's VitalConnect, merging two Bay Area cardiac monitoring players.
iRhythm Holdings stock fell 2.06 percent to a Nasdaq close of USD 104.99 on October 7, 2026, while the company completed its ...
Background Atrial fibrillation (AF) is a common cause of ischaemic stroke and a major global health burden, but is often ...
Newspoint on MSN
Smartwatch ECG vs real doctor: Why your wrist wearable cannot replace a cardiologist
Wristwatches have rapidly transformed from simple timekeeping accessories into sophisticated personal wellness hubs, capable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results